Thorgeirsson SS - Search Results

1

Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.

Im YH, Kim HT, Kim IY, Factor VM, Hahm KB, Anzano M, Jang JJ, Flanders K, Haines DC, Thorgeirsson SS, Sizeland A, Kim SJ. Im YH, et al. Among authors: thorgeirsson ss. Cancer Res. 2001 Sep 15;61(18):6665-8. Cancer Res. 2001. PMID: 11559531

2

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.

Takami T, Kaposi-Novak P, Uchida K, Gomez-Quiroz LE, Conner EA, Factor VM, Thorgeirsson SS. Takami T, et al. Among authors: thorgeirsson ss. Cancer Res. 2007 Oct 15;67(20):9844-51. doi: 10.1158/0008-5472.CAN-07-1905. Cancer Res. 2007. PMID: 17942915

3

Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.

Coulouarn C, Factor VM, Thorgeirsson SS. Coulouarn C, et al. Among authors: thorgeirsson ss. Hepatology. 2008 Jun;47(6):2059-67. doi: 10.1002/hep.22283. Hepatology. 2008. PMID: 18506891 Free PMC article.

4

Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.

Kao CY, Factor VM, Thorgeirsson SS. Kao CY, et al. Among authors: thorgeirsson ss. Biochem Biophys Res Commun. 1996 May 6;222(1):64-70. doi: 10.1006/bbrc.1996.0698. Biochem Biophys Res Commun. 1996. PMID: 8630075

5

Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.

Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS. Factor VM, et al. Among authors: thorgeirsson ss. Cancer Res. 1997 Jun 1;57(11):2089-95. Cancer Res. 1997. PMID: 9187100

6

Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.

Factor VM, Jensen MR, Thorgeirsson SS. Factor VM, et al. Among authors: thorgeirsson ss. Hepatology. 1997 Dec;26(6):1434-43. doi: 10.1002/hep.510260610. Hepatology. 1997. PMID: 9397983

7

Dysregulation of apoptosis in hepatocellular carcinoma.

Thorgeirsson SS, Teramoto T, Factor VM. Thorgeirsson SS, et al. Semin Liver Dis. 1998;18(2):115-22. doi: 10.1055/s-2007-1007148. Semin Liver Dis. 1998. PMID: 9606809 Review.

8

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.

Santoni-Rugiu E, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Among authors: thorgeirsson ss. Am J Pathol. 1999 Jun;154(6):1693-700. doi: 10.1016/s0002-9440(10)65425-9. Am J Pathol. 1999. PMID: 10362794 Free PMC article.

9

Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo.

Bouzahzah B, Fu M, Iavarone A, Factor VM, Thorgeirsson SS, Pestell RG. Bouzahzah B, et al. Among authors: thorgeirsson ss. Cancer Res. 2000 Aug 15;60(16):4531-7. Cancer Res. 2000. PMID: 10969803

10

Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.

Calvisi DF, Factor VM, Loi R, Thorgeirsson SS. Calvisi DF, et al. Among authors: thorgeirsson ss. Cancer Res. 2001 Mar 1;61(5):2085-91. Cancer Res. 2001. PMID: 11280770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters